Metformin, Asian ethnicity and risk of prostate cancer in type 2 diabetes: a systematic review and meta-analysis.

about

Metformin, Asian ethnicity and risk of prostate cancer in type 2 diabetes: a systematic review and meta-analysis.

Item

http://www.wikidata.org/entity/Q48268841

description

2018 nî lūn-bûn

@nan

2018年の論文

@ja

2018年学术文章

@wuu

2018年学术文章

@zh

2018年学术文章

@zh-cn

2018年学术文章

@zh-hans

2018年学术文章

@zh-my

2018年学术文章

@zh-sg

2018年學術文章

@yue

2018年學術文章

@zh-hant

name

Metformin, Asian ethnicity and ...... atic review and meta-analysis.

@en

Metformin, Asian ethnicity and ...... atic review and meta-analysis.

@nl

type

Item

label

Metformin, Asian ethnicity and ...... atic review and meta-analysis.

@en

Metformin, Asian ethnicity and ...... atic review and meta-analysis.

@nl

prefLabel

Metformin, Asian ethnicity and ...... atic review and meta-analysis.

@en

Metformin, Asian ethnicity and ...... atic review and meta-analysis.

@nl

P1476

Metformin, Asian ethnicity and ...... atic review and meta-analysis.

@en

P2093

Dean T Eurich

http://www.w3.org/2001/XMLSchema#string

Jeffrey A Johnson

http://www.w3.org/2001/XMLSchema#string

Maxim Eskin

http://www.w3.org/2001/XMLSchema#string

Sumit R Majumdar

http://www.w3.org/2001/XMLSchema#string

P275

Creative Commons Attribution 4.0 International

P2860

Metformin therapy and risk of cancer in patients with type 2 diabetes: systematic review

Effect of metformin on cancer risk and treatment outcome of prostate cancer: a meta-analysis of epidemiological observational studies

Glycemic durability of rosiglitazone, metformin, or glyburide monotherapy

Significantly increased risk of cancer in diabetes mellitus patients: A meta-analysis of epidemiological evidence in Asians and non-Asians.

Experience of malignancies with oral glucose-lowering drugs in the randomised controlled ADOPT (A Diabetes Outcome Progression Trial) and RECORD (Rosiglitazone Evaluated for Cardiovascular Outcomes and Regulation of Glycaemia in Diabetes) clinical t

Glucose-lowering agents and the patterns of risk for cancer: a study with the General Practice Research Database and secondary care data.

Metformin and cancer risk and mortality: a systematic review and meta-analysis taking into account biases and confounders.

Diabetes and risk of prostate cancer: a study using the National Health Insurance.

The influence of glucose-lowering therapies on cancer risk in type 2 diabetes.

Cohort study of pioglitazone and cancer incidence in patients with diabetes

P2888

s12885-017-3934-9

P304

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

review article

meta-analysis

P356

10.1186/S12885-017-3934-9

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

C B Chen

P5008

ScienceSource

P577

2018-01-10T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P6179

1100302240

http://www.w3.org/2001/XMLSchema#string

P698

29320995

http://www.w3.org/2001/XMLSchema#string

P921

maturity-onset diabetes of the young

P932

5763543

http://www.w3.org/2001/XMLSchema#string